Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Aquestive Therapeutics Inc (AQST)

Healthcare Drug Manufacturers - Specialty & Generic
3.70 $
-0.7% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Aquestive Therapeutics Inc (AQST)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 91.3% of the shares are freely tradable; institutional investors hold 60.6%.

Ownership Structure

Institutional ownership
60.6%
Insiders
3.1%
Float
91.3%
Short % of float
12.4%
Shares Outstanding
126Mio.

Largest Shareholders

Institutions

Institutions AQST
Name Stake (%) Shares Change (%) Date
Bratton Capital Management, L.P. 7.82 9,810,958 +0.0 03/31/2026
BlackRock Inc 5.99 7,509,071 -3.4 03/31/2026
RTW INVESTMENTS, LLC 5.92 7,426,471 +18.8 03/31/2026
Vanguard Group Inc 4.70 5,892,334 +4.1 12/31/2025
Vanguard Capital Management, LLC 3.54 4,443,698 +0.0 03/31/2026
Federated Hermes Inc 2.34 2,940,339 +44.6 03/31/2026
Balyasny Asset Management LLC 2.31 2,900,570 +198.7 03/31/2026
State Street Corp 2.03 2,546,191 +3.4 03/31/2026
Samsara BioCapital, LLC 1.99 2,500,000 +0.0 03/31/2026

Funds

Funds AQST
Name Stake (%) Shares Change (%) Date
Vanguard Total Stock Mkt Idx Inv 2.63 3,294,909 +0.0 04/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
16. Jul 2026 Barber Daniel President and CEO Sell 20,369 4.00 81,509
15. Jul 2026 Barber Daniel President and CEO Sell 4,631 4.03 18,683

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?